Avalo Therapeutics, Inc.
$927.80M- Market cap
- $1.03B
- Debt
- +-$5.17M
- Cash
- −$98.34M
Capital structure 101% equity / -1% debt · EV / Revenue 15725.35x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AVTX · current priceP/S 17479.74x
$19.23Latest market snapshot
Implied fair value · at ESTC's multiple
$0.01100.0% below market
0.00 AVTX revenue / share×5.54x ESTC P/S=$0.01
Market $19.23Implied $0.01
ESTC · current priceP/S 5.54x
$91.81Latest market snapshot
Implied fair value · at AVTX's multiple
$289,576.95315,308.9% above market
16.57 ESTC revenue / share×17479.74x AVTX P/S=$289,576.95
Market $91.81Implied $289,576.95